Market Place
Sourcing Support
All News #Library
Natco’s Generics Cabozantinib Receives Tentative Approval in US
25 Mar 2026 //
FDA
Natco’s Generics Palbociclib Receives Tentative Approval in US
19 Mar 2026 //
FDA
Natco’s Generics Alectinib Receives Approval in US
25 Feb 2026 //
FDA
Nat’s Generics Idelalisib Receives Approval in US
17 Feb 2026 //
FDA
Natco Pharma’s Generics Idelalisib Receives Approval in US
17 Feb 2026 //
FDA
Natco’s Generics Erdafitinib Receives Tentative Approval in US
02 Feb 2026 //
FDA
Natco’s Receives First Generic Approval for Bosentan For in US
05 Feb 2025 //
FDA
Natco Pharma`s Generics Bosentan Receives Approval in US
05 Feb 2025 //
FDA
Natco`s Generic Tipiracil HCL, Trifluridine Receives Approval in the U.S.
13 Jun 2023 //
FDA
Natco Pharma Ltd`s Generic Lapatinib Ditosylate Receives Approval In US
29 Sep 2020 //
FDA
Natco Pharma’s Generic Gefitinib Receives Tentative Approval In US
30 Jul 2020 //
FDA
Natco Pharma’s Generic Erlotinib Hydrochloride Receives Approval In US
07 Nov 2019 //
FDA
Natco Pharma’s Generic Imatinib Mesylat Receives Approval In US
05 Mar 2019 //
FDA
Natco`s Generic Armodafinil Receives Approval In US
28 Nov 2016 //
FDA
NATCO Pharma Receives FDA Nod For Generic Tamiflu
03 Aug 2016 //
FDA
Natco Pharma`s Generic Glycopyrrolate Approved in US
20 Jun 2016 //
FDA
Natco Pharma`s Generic Lansoprazole approved in US for treatment of Ulcers
13 Jan 2015 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.